The aim of this study was to evaluate the performance of multiparametric magnetic resonance imaging (mpMRI)-ultrasound (US) fusion-targeted biopsies (TB) in men with primary and repeated biopsies comparing the cancer detection rate (CDR) of random biopsies (RB) + TB versus only TB.
MRI ultrasound fusion biopsy in prostate cancer detection: Are randomized clinical trials reproducible in everyday clinical practice? / Cattarino, S., Forte, V., Salciccia, S., Drudi, F.M., Cantisani, V., Sciarra, A., Fasulo, A., Ciccariello, M.. - In: UROLOGIA. - ISSN 0391-5603. - 86:1(2019), pp. 9-16-16. [10.1177/0391560319834490]
MRI ultrasound fusion biopsy in prostate cancer detection: Are randomized clinical trials reproducible in everyday clinical practice?
Cattarino, Susanna;Forte, Valerio;Salciccia, Stefano;Drudi, Francesco Maria;Sciarra, Alessandro;FASULO, ANDREA;Ciccariello, Mauro
2019
Abstract
The aim of this study was to evaluate the performance of multiparametric magnetic resonance imaging (mpMRI)-ultrasound (US) fusion-targeted biopsies (TB) in men with primary and repeated biopsies comparing the cancer detection rate (CDR) of random biopsies (RB) + TB versus only TB.File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
